Discovery of 4-((3,4-dichlorophenyl)amino)-2-methylquinolin-6-ol derivatives as EGFR and HDAC dual inhibitors.
Qian Y, Zhou S, Li J, Ma M, Chen H, Cao Y, Zhang Y, Sun C, Li K, Liu Y, Dai S, Ao M, Fang M, Wu Z, Li M.
Qian Y, et al. Among authors: cao y.
Eur J Pharmacol. 2023 Dec 5;960:176114. doi: 10.1016/j.ejphar.2023.176114. Epub 2023 Oct 19.
Eur J Pharmacol. 2023.
PMID: 37863412